TRIM33 and non-small cell lung carcinoma: TRIM33 is identified as a downstream target of SOX2 in NSCLC cells, where SOX2 represses TIF1γ transcription, impairing its function and playing a crucial role in TGF-β-induced EMT and cell invasion [148].